Literature DB >> 3714047

The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

E R Maher, A J Lees.   

Abstract

We analyzed the clinical features and natural history of 52 consecutive patients with the Steele-Richardson-Olszewski syndrome. The most common symptoms at onset were unsteady gait, backward falls because of poor balance, visual disturbances, slurred speech, and forgetfulness. The median duration from onset to death was 5.9 years, with a median survival after diagnosis of only 1.8 years. Bronchopneumonia was the usual cause of death recorded on death certificates.

Entities:  

Mesh:

Year:  1986        PMID: 3714047     DOI: 10.1212/wnl.36.7.1005

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

1.  Diagnosis and management of atypical parkinsonian syndromes.

Authors:  David J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

2.  Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.

Authors:  H Karbe; M Grond; M Huber; K Herholz; J Kessler; W D Heiss
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

3.  Descending brainstem projections of the pedunculopontine tegmental nucleus in the rat.

Authors:  I Grofova; S Keane
Journal:  Anat Embryol (Berl)       Date:  1991

4.  Progressive supranuclear palsy presenting with dynamic aphasia.

Authors:  T Esmonde; E Giles; J Xuereb; J Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

5.  Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).

Authors:  U Nath; R Thomson; R Wood; Y Ben-Shlomo; A Lees; C Rooney; D Burn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

6.  Progressive Supranuclear Palsy and Corticobasal Degeneration.

Authors:  David G Coughlin; Dennis W Dickson; Keith A Josephs; Irene Litvan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy.

Authors:  T Esmonde; E Giles; M Gibson; J R Hodges
Journal:  J Neurol       Date:  1996-09       Impact factor: 4.849

8.  Striatonigral degeneration with neurofibrillary tangles.

Authors:  K Renkawek; M W Horstink
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

9.  Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

Authors:  S J Collins; J E Ahlskog; J E Parisi; D M Maraganore
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

10.  Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.

Authors:  I Litvan; C A Mangone; A McKee; M Verny; A Parsa; K Jellinger; L D'Olhaberriague; K R Chaudhuri; R K Pearce
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.